Agency Information Collection Activities: Proposed Collection; Comment Request, 65170 [2019-25647]
Download as PDF
<![CDATA[
65170
Federal Register / Vol. 84, No. 228 / Tuesday, November 26, 2019 / Notices
all U.S. and foreign patents and
applications claiming priority to any
member of the above.
The patent rights in these inventions
have been assigned or exclusively
licensed to the Government of the
United States of America.
The prospective exclusive license
territory may be worldwide and in fields
of use that may be limited to human
therapeutics for (1) X-linked juvenile
retinoschisis and (2) schisis cavity
associated ocular disease or injury.
The aforementioned patent estates
cover inventions directed to gene
therapy and specifically, expression
vectors and therapeutic methods of
using such vectors in the treatment of
ocular diseases resulting from failure to
produce or the defective production of
an ocular protein. This invention is also
directed to methods of administering
expression vectors capable of
modulating a target gene or gene
product for the treatment of ocular
disease.
This notice is made in accordance
with 35 U.S.C. 209 and 37 CFR part 404.
The prospective exclusive license will
be royalty bearing. The prospective
exclusive license may be granted unless
within thirty ( ) days from the date of
this published notice, the National
Heart, Lung, and Blood Institute
receives written evidence and argument
that establishes that the grant of the
license would not be consistent with the
requirements of 35 U.S.C. 209 and 37
CFR part 404.
In response to this Notice, the public
may file comments or objections.
Comments and objections, other than
those in the form of a license
application, will not be treated
confidentially, and may be made
publicly available.
License applications submitted in
response to this notice will be presumed
to contain business confidential
information and any release of
information in these license
applications will be made only as
required and upon a request under the
Freedom of Information Act, 5 U.S.C.
552.
Dated: November 21, 2019.
Michael A. Shmilovich,
Senior Licensing and Patenting Manager,
National Heart, Lung, and Blood Institute.
[FR Doc. 2019–25685 Filed 11–25–19; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
16:47 Nov 25, 2019
Jkt 250001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Proposed Collection;
Comment Request
In compliance with Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
Reports Clearance Officer on (240) 276–
1243.
Comments are invited on: (a) Whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Proposed Project: 2020–2023 National
Survey on Drug Use and Health:
Methodological Field Tests (OMB No.
0930–0290)—Extension
The National Survey on Drug Use and
Health (NSDUH) is a survey of the U.S.
civilian, non-institutionalized
population aged 12 years old or older.
The data are used to determine the
prevalence of use of tobacco products,
alcohol, illicit substances, and illicit use
of prescription drugs. The results are
used by SAMHSA, the Office of
National Drug Control Policy (ONDCP),
federal government agencies, and other
organizations and researchers to
establish policy, direct program
activities, and better allocate resources.
Methodological tests will continue to
be designed to examine the feasibility,
quality, and efficiency of new
procedures or revisions to existing
survey protocol. Specifically, the tests
will measure the reliability and validity
of certain questionnaire sections and
items through multiple measurements
on a set of respondents; assess new
methods for gaining cooperation and
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
participation of respondents with the
goal of increasing response and
decreasing potential bias in the survey
estimates; and assess the impact of new
sampling techniques and technologies
on respondent behavior and reporting.
Research will involve focus groups,
cognitive laboratory testing, customer
satisfaction surveys, and field tests.
These methodological tests will
continue to examine ways to increase
data quality, lower operating costs, and
gain a better understanding of sources
and effects of nonsampling error on
NSDUH estimates. Particular attention
will be given to minimizing the impact
of design changes so survey data
continue to remain comparable over
time. If these tests provide successful
results, current procedures or data
collection instruments may be revised.
The number of respondents to be
included in each field test will vary,
depending on the nature of the subject
being tested and the target population.
However, the total estimated response
burden is 8,225 hours. The exact
number of subjects and burden hours for
each test are unknown at this time, but
will be clearly outlined in each
individual submission. These estimated
burden hours are distributed over three
years as follows:
TABLE 1—ESTIMATED BURDEN FOR
NSDUH METHODOLOGICAL FIELD
TESTS
Time period
Respondent
burden hours
May 2020 to May 2021 ........
May 2021 to May 2022 ........
May 2022 to May 2023 ........
2,742
2,742
2,741
Total ...............................
8,225
Send comments to Summer King,
SAMHSA Reports Clearance Officer,
5600 Fishers Lane, Room 15E57–B,
Rockville, Maryland 20857, OR email a
copy to summer.king@samhsa.hhs.gov.
Written comments should be received
by January 27, 2020.
Summer King,
Statistician.
[FR Doc. 2019–25647 Filed 11–25–19; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HOUSING AND
URBAN DEVELOPMENT
[Docket No. FR–6190–N–01]
Notice of Intent To Close Reno Field
Office
Office of Field Policy and
Management, HUD.
AGENCY:
E:\FR\FM\26NON1.SGM
26NON1
]]>Agencies
[Federal Register Volume 84, Number 228 (Tuesday, November 26, 2019)]
[Notices]
[Page 65170]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-25647]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Proposed Collection;
Comment Request
In compliance with Section 3506(c)(2)(A) of the Paperwork Reduction
Act of 1995 concerning opportunity for public comment on proposed
collections of information, the Substance Abuse and Mental Health
Services Administration (SAMHSA) will publish periodic summaries of
proposed projects. To request more information on the proposed projects
or to obtain a copy of the information collection plans, call the
SAMHSA Reports Clearance Officer on (240) 276-1243.
Comments are invited on: (a) Whether the proposed collections of
information are necessary for the proper performance of the functions
of the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology.
Proposed Project: 2020-2023 National Survey on Drug Use and Health:
Methodological Field Tests (OMB No. 0930-0290)--Extension
The National Survey on Drug Use and Health (NSDUH) is a survey of
the U.S. civilian, non-institutionalized population aged 12 years old
or older. The data are used to determine the prevalence of use of
tobacco products, alcohol, illicit substances, and illicit use of
prescription drugs. The results are used by SAMHSA, the Office of
National Drug Control Policy (ONDCP), federal government agencies, and
other organizations and researchers to establish policy, direct program
activities, and better allocate resources.
Methodological tests will continue to be designed to examine the
feasibility, quality, and efficiency of new procedures or revisions to
existing survey protocol. Specifically, the tests will measure the
reliability and validity of certain questionnaire sections and items
through multiple measurements on a set of respondents; assess new
methods for gaining cooperation and participation of respondents with
the goal of increasing response and decreasing potential bias in the
survey estimates; and assess the impact of new sampling techniques and
technologies on respondent behavior and reporting. Research will
involve focus groups, cognitive laboratory testing, customer
satisfaction surveys, and field tests.
These methodological tests will continue to examine ways to
increase data quality, lower operating costs, and gain a better
understanding of sources and effects of nonsampling error on NSDUH
estimates. Particular attention will be given to minimizing the impact
of design changes so survey data continue to remain comparable over
time. If these tests provide successful results, current procedures or
data collection instruments may be revised.
The number of respondents to be included in each field test will
vary, depending on the nature of the subject being tested and the
target population. However, the total estimated response burden is
8,225 hours. The exact number of subjects and burden hours for each
test are unknown at this time, but will be clearly outlined in each
individual submission. These estimated burden hours are distributed
over three years as follows:
Table 1--Estimated Burden for NSDUH Methodological Field Tests
------------------------------------------------------------------------
Respondent
Time period burden hours
------------------------------------------------------------------------
May 2020 to May 2021.................................... 2,742
May 2021 to May 2022.................................... 2,742
May 2022 to May 2023.................................... 2,741
---------------
Total............................................... 8,225
------------------------------------------------------------------------
Send comments to Summer King, SAMHSA Reports Clearance Officer,
5600 Fishers Lane, Room 15E57-B, Rockville, Maryland 20857, OR email a
copy to [email protected]. Written comments should be received
by January 27, 2020.
Summer King,
Statistician.
[FR Doc. 2019-25647 Filed 11-25-19; 8:45 am]
BILLING CODE 4162-20-P
